Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. 1995

J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
Department of Bacteriology and Virology, Hôpital Henri Mondor, Université Paris XII, Créteil, France.

Ninety-six patients with chronic hepatitis C were studied. A second-generation recombinant immunoblot assay detected anti-NS4 antibodies significantly more often in patients infected by hepatitis C virus genotype 1 than in patients infected by other types. By a third-generation recombinant immunoblot assay, the prevalences of the four antibodies measured did not differ according to the hepatitis C virus genotype.

UI MeSH Term Description Entries
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014773 Virology The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
January 1997, Journal of clinical microbiology,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
July 1994, Journal of medical virology,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
August 1994, The Journal of infectious diseases,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
February 1998, Journal of clinical microbiology,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
January 1992, Archives of virology. Supplementum,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
June 1990, Lancet (London, England),
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
January 1996, Journal of clinical microbiology,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
January 1993, Journal of clinical laboratory analysis,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
September 1995, Transfusion,
J M Pawlotsky, and F Roudot-Thoraval, and C Pellet, and P Aumont, and F Darthuy, and J Remire, and J Duval, and D Dhumeaux
April 1990, Lancet (London, England),
Copied contents to your clipboard!